Hsp90 is a potential risk factor for ovarian cancer prognosis: an evidence of a Chinese clinical center
Abstract Background The potential treatment effects of heat shock protein 90 (Hsp90) inhibitors in ovarian cancer (OC) are controversial. This research aims to investigate the relationship between the level of Hsp90 in peripheral blood and the prognosis of OC patients, as well as the clinicopatholog...
| Published in: | BMC Cancer |
|---|---|
| Main Authors: | , , , , |
| Format: | Article |
| Language: | English |
| Published: |
BMC
2023-05-01
|
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12885-023-10929-9 |
